Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Download PDF
May 3, 2016
/
News
Share
the Post
Related
Posts
Progress report on access to hepatitis C treatment, WHO March 2018
Hepatitis C Treatment Snapshots: Daclatasvir
New WHO guideline on care and treatment of chronic hepatitis C
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
Updated Generic Sofosbuvir Availability and Price in India 15 June 2015
Support letter for inclusion of Daclatasvir on 4th March, 2015.
A two pager of what you need to know of Sofosbuvir
Read More
Story from Ayu Oktariani, Bandung, Indonesia
